196 related items for PubMed ID: 8089635
21. Safety of the combination of valsartan and benazepril in patients with chronic renal disease. European Group for the Investigation of Valsartan in Chronic Renal Disease.
Ruilope LM, Aldigier JC, Ponticelli C, Oddou-Stock P, Botteri F, Mann JF.
J Hypertens; 2000 Jan; 18(1):89-95. PubMed ID: 10678548
[Abstract] [Full Text] [Related]
22. Effect of dopamine on renal function after arteriography in patients with pre-existing renal insufficiency.
Hans SS, Hans BA, Dhillon R, Dmuchowski C, Glover J.
Am Surg; 1998 May; 64(5):432-6. PubMed ID: 9585778
[Abstract] [Full Text] [Related]
23. [The ACE inhibitor spirapril in chronic renal failure, hypertension and diabetic nephropathy].
Elliot HL.
Ter Arkh; 2000 May; 72(10):78-82. PubMed ID: 11220886
[Abstract] [Full Text] [Related]
24. High serum enalaprilat in chronic renal failure.
Elung-Jensen T, Heisterberg J, Kamper AL, Sonne J, Strandgaard S, Larsen NE.
J Renin Angiotensin Aldosterone Syst; 2001 Dec; 2(4):240-5. PubMed ID: 11881130
[Abstract] [Full Text] [Related]
25. Use of allopurinol in slowing the progression of renal disease through its ability to lower serum uric acid level.
Siu YP, Leung KT, Tong MK, Kwan TH.
Am J Kidney Dis; 2006 Jan; 47(1):51-9. PubMed ID: 16377385
[Abstract] [Full Text] [Related]
26. [Lercanidipine in diabetic patients with renal failure].
Robles NR, Pastor L, Manjón M, Ocón J, Gómez Campderá F, Herrera J, Villatoro J, Calls J, Torrijos J, Rodríguez Villareal I, Rodríguez Martínez MA, Méndez ML, Morey A, Martínez Fernández J, Marco J, Liébana A, Rincón B, Tornero F.
Nefrologia; 2004 Jan; 24(4):338-43. PubMed ID: 15455493
[Abstract] [Full Text] [Related]
27. Hypertension and nephrotoxicity in the rate of decline in kidney function in diabetic nephropathy.
Aubia J, Hojman L, Chine M, Lloveras J, Masramon J, Llorach I, Cuevas X, Puig JM.
Clin Nephrol; 1987 Jan; 27(1):15-20. PubMed ID: 3815904
[Abstract] [Full Text] [Related]
28. Blood pressure and progression of renal failure in the elderly.
Acone D, Cante D, Cillo F, Giordano G, Giordano C.
Kidney Int Suppl; 1996 Jun; 55():S75-7. PubMed ID: 8743516
[Abstract] [Full Text] [Related]
29. The effects of amlodipine and enalapril on renal function in adults with hypertension and nondiabetic nephropathies: a 3-year, randomized, multicenter, double-blind, placebo-controlled study.
Esnault VL, Brown EA, Apetrei E, Bagon J, Calvo C, DeChatel R, Holdaas H, Krcmery S, Kobalava Z, Amlodipine Versus Enalapril in Renal failure (AVER) Study Group.
Clin Ther; 2008 Mar; 30(3):482-98. PubMed ID: 18405787
[Abstract] [Full Text] [Related]
30. Blood pressure reduction associated with preservation of renal function in hypertensive patients with IgA nephropathy: a 3-year follow-up.
Kanno Y, Okada H, Saruta T, Suzuki H.
Clin Nephrol; 2000 Nov; 54(5):360-5. PubMed ID: 11105796
[Abstract] [Full Text] [Related]
31. Prevention and treatment of diabetic nephropathy.
Wittmann I, Molnár GA, Degrell P, Wagner Z, Tamaskó M, Laczy B, Brasnyó P, Wagner L, Nagy J.
Diabetes Res Clin Pract; 2005 Jun; 68 Suppl1():S36-42. PubMed ID: 15955373
[Abstract] [Full Text] [Related]
32. Effects of gender, Helicobacter pylori and hepatitis B virus serology status on cardiovascular and renal complications in Chinese type 2 diabetic patients with overt nephropathy.
Lo MK, Lee KF, Chan NN, Leung WY, Ko GT, Chan WB, So WY, Ng MC, Ho CS, Tam JS, Lam CW, Tong PC, Chan JC.
Diabetes Obes Metab; 2004 May; 6(3):223-30. PubMed ID: 15056131
[Abstract] [Full Text] [Related]
33. Inhibitors of the renin-angiotensin system reduce the rate of GFR decline and end-stage renal disease in patients with severe renal insufficiency.
Pisoni R, Faraone R, Ruggenent P, Remuzzi G.
J Nephrol; 2002 May; 15(4):428-30. PubMed ID: 12243375
[Abstract] [Full Text] [Related]
34. Renal pathology and proteinuria determine progression in untreated mild/moderate chronic renal failure.
Williams PS, Fass G, Bone JM.
Q J Med; 1988 Apr; 67(252):343-54. PubMed ID: 3205906
[Abstract] [Full Text] [Related]
35. Association of reduced red blood cell deformability and diabetic nephropathy.
Brown CD, Ghali HS, Zhao Z, Thomas LL, Friedman EA.
Kidney Int; 2005 Jan; 67(1):295-300. PubMed ID: 15610255
[Abstract] [Full Text] [Related]
36. [Effect of enalapril on progression of chronic renal insufficiency caused by diabetes and other etiologies: a 2-year study].
Trbojević J, Stojimirović B.
Srp Arh Celok Lek; 2002 Jan; 130(3-4):87-90. PubMed ID: 12154520
[Abstract] [Full Text] [Related]
37. Angiotensin-converting enzyme inhibition in nondiabetic progressive renal insufficiency: a controlled double-blind trial.
Ihle BU, Whitworth JA, Shahinfar S, Cnaan A, Kincaid-Smith PS, Becker GJ.
Am J Kidney Dis; 1996 Apr; 27(4):489-95. PubMed ID: 8678058
[Abstract] [Full Text] [Related]
38. Long-term preservation of renal function in hypertensive heart transplant recipients treated with enalapril and a diuretic.
Elliott WJ, Murphy MB, Karp R.
J Heart Lung Transplant; 1991 Apr; 10(3):373-9. PubMed ID: 1854764
[Abstract] [Full Text] [Related]
39. [Nicardipine, alone or in combination with enalapril, in the therapy of arterial hypertension secondary to chronic nephropathy].
Pecci G, Feriozzi S, Morabito S, Mavrikakis G, Roscia E, Simonetti BM, Pierucci A.
Clin Ter; 1989 Sep 30; 130(6):327-32. PubMed ID: 2572374
[Abstract] [Full Text] [Related]
40. Treatment of renal failure from diabetic nephropathy with cadaveric homograft.
Beaudry C, Laplate L.
Can Med Assoc J; 1973 Apr 07; 108(7):887-8 passim. PubMed ID: 4574972
[Abstract] [Full Text] [Related]
Page: [Previous] [Next] [New Search]
